메뉴 건너뛰기




Volumn 12, Issue , 2012, Pages

The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study

Author keywords

Arterial hypertension; Genotype; GIST; Predictive factors; Prognosis; Sunitinib

Indexed keywords

IMATINIB; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; STEM CELL FACTOR RECEPTOR; SUNITINIB; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2; ANTINEOPLASTIC AGENT; INDOLE DERIVATIVE; PIPERAZINE DERIVATIVE; PROTEIN KINASE INHIBITOR; PYRIMIDINE DERIVATIVE; PYRROLE DERIVATIVE; VEGFA PROTEIN, HUMAN;

EID: 84858713323     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-107     Document Type: Article
Times cited : (61)

References (48)
  • 3
    • 33749623419 scopus 로고    scopus 로고
    • Gastrointestinal stromal tumor (GIST)
    • 10.1093/annonc/mdl274, 17018739
    • Joensuu H. Gastrointestinal stromal tumor (GIST). Ann Oncol 2006, 17(Suppl 10):x280-x286. 10.1093/annonc/mdl274, 17018739.
    • (2006) Ann Oncol , vol.17 , Issue.SUPPL. 10
    • Joensuu, H.1
  • 4
    • 44449178477 scopus 로고    scopus 로고
    • Gastrointestinal stromal tumors: key to diagnosis and choice of therapy
    • Rutkowski P, Debiec-Rychter M, Ruka W. Gastrointestinal stromal tumors: key to diagnosis and choice of therapy. Mol Diagn Ther 2008, 12(3):131-143.
    • (2008) Mol Diagn Ther , vol.12 , Issue.3 , pp. 131-143
    • Rutkowski, P.1    Debiec-Rychter, M.2    Ruka, W.3
  • 6
    • 78650874372 scopus 로고    scopus 로고
    • SU11248 inhibits KIT and platelet-derived growth factor receptor beta in preclinical models of human small cell lung cancer
    • Abrams TJ, Lee LB, Murray LJ, Pryer NK, Cherrington JM. SU11248 inhibits KIT and platelet-derived growth factor receptor beta in preclinical models of human small cell lung cancer. Mol Cancer Ther 2003, 2:471-478.
    • (2003) Mol Cancer Ther , vol.2 , pp. 471-478
    • Abrams, T.J.1    Lee, L.B.2    Murray, L.J.3    Pryer, N.K.4    Cherrington, J.M.5
  • 14
    • 36749082718 scopus 로고    scopus 로고
    • Subpopulation analyses in a worldwide treatment-use trial of sunitinib (SU) in GIST patients (pts) with resistance or intolerance to prior imatinib (IM) therapy
    • Reichardt P, Kang YK, Ruka W, Seddon B, Baum CM, Demetri GD. Subpopulation analyses in a worldwide treatment-use trial of sunitinib (SU) in GIST patients (pts) with resistance or intolerance to prior imatinib (IM) therapy. J Clin Oncol 2007, 25(18S):Abs 10022..
    • (2007) J Clin Oncol , vol.25 , Issue.18 S
    • Reichardt, P.1    Kang, Y.K.2    Ruka, W.3    Seddon, B.4    Baum, C.M.5    Demetri, G.D.6
  • 15
    • 60549113344 scopus 로고    scopus 로고
    • Blood pressure as a potential biomarker of the efficacy angiogenesis inhibitor
    • Levy BI. Blood pressure as a potential biomarker of the efficacy angiogenesis inhibitor. Ann Oncol 2009, 20:200-203.
    • (2009) Ann Oncol , vol.20 , pp. 200-203
    • Levy, B.I.1
  • 16
    • 79955767772 scopus 로고    scopus 로고
    • Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
    • 10.1093/jnci/djr128, 3086879, 21527770
    • Rini BI, Cohen DP, Lu DR, Chen I, Hariharan S, Gore ME, Figlin RA, Baum MS, Motzer RJ. Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib. J Natl Cancer Inst 2011, 103:763-773. 10.1093/jnci/djr128, 3086879, 21527770.
    • (2011) J Natl Cancer Inst , vol.103 , pp. 763-773
    • Rini, B.I.1    Cohen, D.P.2    Lu, D.R.3    Chen, I.4    Hariharan, S.5    Gore, M.E.6    Figlin, R.A.7    Baum, M.S.8    Motzer, R.J.9
  • 18
    • 12344312699 scopus 로고    scopus 로고
    • Common terminology criteria for adverse events version 3.0 (CTCAE)
    • Bethesda, MD: National Cancer Institute, Cancer therapy evaluation program
    • Cancer therapy evaluation program Common terminology criteria for adverse events version 3.0 (CTCAE). 2003, Bethesda, MD: National Cancer Institute, (Available at http://ctep.cancer.gov/forms/CTCAEv3.pdf), Cancer therapy evaluation program.
    • (2003)
  • 20
    • 77949535841 scopus 로고    scopus 로고
    • Pharmacological management of gastrointestinal stromal tumours: an update on the role of sunitinib
    • 10.1093/annonc/mdp291, 19675092
    • Blay J-Y. Pharmacological management of gastrointestinal stromal tumours: an update on the role of sunitinib. Ann Oncol 2010, 21:208-215. 10.1093/annonc/mdp291, 19675092.
    • (2010) Ann Oncol , vol.21 , pp. 208-215
    • Blay, J.-Y.1
  • 21
    • 79956061416 scopus 로고    scopus 로고
    • Comparison of RECIST and Choi criteria for computed tomographic response evaluation in patients with advanced gastrointestinal stromal tumor treated with sunitinib
    • 10.1093/annonc/mdq696, 21289369
    • Dudeck O, Zeile M, Reichardt P, Pink D. Comparison of RECIST and Choi criteria for computed tomographic response evaluation in patients with advanced gastrointestinal stromal tumor treated with sunitinib. Ann Oncol 2011, 22(8):1828-1833. 10.1093/annonc/mdq696, 21289369.
    • (2011) Ann Oncol , vol.22 , Issue.8 , pp. 1828-1833
    • Dudeck, O.1    Zeile, M.2    Reichardt, P.3    Pink, D.4
  • 22
    • 84862253645 scopus 로고    scopus 로고
    • Sunitinib as a second-line therapy for advanced GISTs after failure of imatinib: relationship between efficacy and tumor genotype in Korean patients
    • doi 10.1007/s10637-010-9593-1 S2
    • Yoon DH, Ryu M-H, Ryoo B-Y, Beck M, Choi D-R, Cho Y, Lee Y-L, Chang H-M, Kim TW, Kang Y-K. Sunitinib as a second-line therapy for advanced GISTs after failure of imatinib: relationship between efficacy and tumor genotype in Korean patients. Invest New Drugs 2011, doi 10.1007/s10637-010-9593-1 S2.
    • (2011) Invest New Drugs
    • Yoon, D.H.1    Ryu, M.-H.2    Ryoo, B.-Y.3    Beck, M.4    Choi, D.-R.5    Cho, Y.6    Lee, Y.-L.7    Chang, H.-M.8    Kim, T.W.9    Kang, Y.-K.10
  • 25
    • 72549086618 scopus 로고    scopus 로고
    • Mechanisms of sunitinib resistance in gastrointestinal stromal tumors harboring KITAY502-3ins mutation: an in vitro mutagenesis screen for drug resistance
    • 10.1158/1078-0432.CCR-09-1315, 2783687, 19861442
    • Guo T, Hajdu M, Agaram NP, Shinoda H, Veach D, Clarkson BD, Maki RG, Singer S, Dematteo RP, Besmer P, Antonescu CR. Mechanisms of sunitinib resistance in gastrointestinal stromal tumors harboring KITAY502-3ins mutation: an in vitro mutagenesis screen for drug resistance. Clin Cancer Res 2009, 15(22):6862-6870. 10.1158/1078-0432.CCR-09-1315, 2783687, 19861442.
    • (2009) Clin Cancer Res , vol.15 , Issue.22 , pp. 6862-6870
    • Guo, T.1    Hajdu, M.2    Agaram, N.P.3    Shinoda, H.4    Veach, D.5    Clarkson, B.D.6    Maki, R.G.7    Singer, S.8    Dematteo, R.P.9    Besmer, P.10    Antonescu, C.R.11
  • 26
    • 65349155963 scopus 로고    scopus 로고
    • Sunitinib-resistant gastrointestinal stromal tumors harbor cis-mutations in the activation loop of the KIT gene
    • 10.1007/s10147-008-0822-y, 19390946
    • Nishida T, Takahashi T, Nishitani A, Doi T, Shirao K, Komatsu Y, Nakajima K, Hirota S. Sunitinib-resistant gastrointestinal stromal tumors harbor cis-mutations in the activation loop of the KIT gene. Int J Clin Oncol 2009, 14(2):143-149. 10.1007/s10147-008-0822-y, 19390946.
    • (2009) Int J Clin Oncol , vol.14 , Issue.2 , pp. 143-149
    • Nishida, T.1    Takahashi, T.2    Nishitani, A.3    Doi, T.4    Shirao, K.5    Komatsu, Y.6    Nakajima, K.7    Hirota, S.8
  • 27
    • 77950617070 scopus 로고    scopus 로고
    • Function of activation loop tyrosine phosphorylation in the mechanism of c-Kit auto-activation and its implication in sunitinib resistance
    • 10.1093/jb/mvq015, 20147452
    • DiNitto JP, Deshmukh GD, Zhang Y, Jacques SL, Coli R, Worrall JW, Diehl W, English JM, Wu JC. Function of activation loop tyrosine phosphorylation in the mechanism of c-Kit auto-activation and its implication in sunitinib resistance. J Biochem 2010, 147(4):601-609. 10.1093/jb/mvq015, 20147452.
    • (2010) J Biochem , vol.147 , Issue.4 , pp. 601-609
    • DiNitto, J.P.1    Deshmukh, G.D.2    Zhang, Y.3    Jacques, S.L.4    Coli, R.5    Worrall, J.W.6    Diehl, W.7    English, J.M.8    Wu, J.C.9
  • 32
    • 48349122489 scopus 로고    scopus 로고
    • The clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation
    • 10.1038/sj.bjc.6604497, 2527784, 18665181
    • Wolter P, Stefan C, Decallonne B, Dumez H, Bex M, Carmeliet P, Schoeffski P. The clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation. Br J Cancer 2008, 99:448-454. 10.1038/sj.bjc.6604497, 2527784, 18665181.
    • (2008) Br J Cancer , vol.99 , pp. 448-454
    • Wolter, P.1    Stefan, C.2    Decallonne, B.3    Dumez, H.4    Bex, M.5    Carmeliet, P.6    Schoeffski, P.7
  • 33
    • 58749112673 scopus 로고    scopus 로고
    • Emergency surgery due to complications during molecular targeted therapy in advanced gastrointestinal stromal tumors (GIST)
    • abstr 82
    • Ruka W, Rutkowski P, Nowecki Z, Dziewirski W. Emergency surgery due to complications during molecular targeted therapy in advanced gastrointestinal stromal tumors (GIST). Ann Surg Oncol 2008, 15(Suppl 2):27. abstr 82.
    • (2008) Ann Surg Oncol , vol.15 , Issue.SUPPL. 2 , pp. 27
    • Ruka, W.1    Rutkowski, P.2    Nowecki, Z.3    Dziewirski, W.4
  • 34
    • 58749097799 scopus 로고    scopus 로고
    • Emergency surgery in the era of molecular treatment of solid tumors
    • 10.1016/S1470-2045(09)70017-8, 19185833
    • Rutkowski P, Ruka W. Emergency surgery in the era of molecular treatment of solid tumors. Lancet Oncol 2009, 10(2):157-163. 10.1016/S1470-2045(09)70017-8, 19185833.
    • (2009) Lancet Oncol , vol.10 , Issue.2 , pp. 157-163
    • Rutkowski, P.1    Ruka, W.2
  • 36
    • 58149098429 scopus 로고    scopus 로고
    • Risk of hypertension and renal dysfunction with an angiogenesis inhibitor sunitinib: systematic review and meta-analysis
    • 10.1080/02841860802314720, 18752081
    • Zhu X, Stergiopoulos K, Wu S. Risk of hypertension and renal dysfunction with an angiogenesis inhibitor sunitinib: systematic review and meta-analysis. Acta Oncol 2009, 48(1):9-17. 10.1080/02841860802314720, 18752081.
    • (2009) Acta Oncol , vol.48 , Issue.1 , pp. 9-17
    • Zhu, X.1    Stergiopoulos, K.2    Wu, S.3
  • 37
    • 65549119311 scopus 로고    scopus 로고
    • Arterial hypertension and clinical benefit of sunitinib, sorafenib and bevacizumab in first and second-line treatment of metastatic renal cell cancer
    • 10.1093/annonc/mdp201, 19403939
    • Ravaud A, Sire M. Arterial hypertension and clinical benefit of sunitinib, sorafenib and bevacizumab in first and second-line treatment of metastatic renal cell cancer. Ann Oncol 2009, 20:966-967. 10.1093/annonc/mdp201, 19403939.
    • (2009) Ann Oncol , vol.20 , pp. 966-967
    • Ravaud, A.1    Sire, M.2
  • 39
    • 79955623124 scopus 로고    scopus 로고
    • Hypertension as predictor of sunitinib treatment outcome in metastatic renal cell carcinoma
    • Epub 2011 Jan 5, 10.3109/0284186X.2010.543696, 21208033
    • Bono P, Rautiola J, Utriainen T, Joensuu H. Hypertension as predictor of sunitinib treatment outcome in metastatic renal cell carcinoma. Acta Oncol 2011, 50(4):569-73. Epub 2011 Jan 5, 10.3109/0284186X.2010.543696, 21208033.
    • (2011) Acta Oncol , vol.50 , Issue.4 , pp. 569-573
    • Bono, P.1    Rautiola, J.2    Utriainen, T.3    Joensuu, H.4
  • 40
    • 0031943236 scopus 로고    scopus 로고
    • VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells
    • Hood JD, Meininger CJ, Ziche M, Granger HJ. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol 1998, 274(3, pt 2):H1054-H1058.
    • (1998) Am J Physiol , vol.274 , Issue.3 PART 2
    • Hood, J.D.1    Meininger, C.J.2    Ziche, M.3    Granger, H.J.4
  • 42
    • 77952242619 scopus 로고    scopus 로고
    • Vascular endothelial growth factor polymorphisms: role in response and toxicity of tyrosine kinase inhibitors
    • 10.1007/s11912-010-0085-4, 20425594
    • Vaziri SA, Kim J, Ganapathi MK, Ganapathi R. Vascular endothelial growth factor polymorphisms: role in response and toxicity of tyrosine kinase inhibitors. Curr Oncol Rep 2010, 12:102-108. 10.1007/s11912-010-0085-4, 20425594.
    • (2010) Curr Oncol Rep , vol.12 , pp. 102-108
    • Vaziri, S.A.1    Kim, J.2    Ganapathi, M.K.3    Ganapathi, R.4
  • 43
    • 84863338437 scopus 로고    scopus 로고
    • Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients treated with sunitinib
    • doi: 10.1002/cncr.26491
    • Kim JJ, Vaziri SA, Rini BI, Elson P, Garcia JA, Wirka R, Dreicer R, Ganapathi MK, Ganapathi R. Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients treated with sunitinib. Cancer 2011, doi: 10.1002/cncr.26491.
    • (2011) Cancer
    • Kim, J.J.1    Vaziri, S.A.2    Rini, B.I.3    Elson, P.4    Garcia, J.A.5    Wirka, R.6    Dreicer, R.7    Ganapathi, M.K.8    Ganapathi, R.9
  • 44
    • 69949107753 scopus 로고    scopus 로고
    • The role of vascular endothelial growth factor genetic variability in cancer
    • 10.1158/1078-0432.CCR-08-2576, 19706811
    • Schneider BP, Radovich M, Miller KD. The role of vascular endothelial growth factor genetic variability in cancer. Clin Cancer Res 2009, 15:5297-5302. 10.1158/1078-0432.CCR-08-2576, 19706811.
    • (2009) Clin Cancer Res , vol.15 , pp. 5297-5302
    • Schneider, B.P.1    Radovich, M.2    Miller, K.D.3
  • 45
    • 70349499022 scopus 로고    scopus 로고
    • The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors
    • 10.1158/1535-7163.MCT-09-0302, 2751847, 19755511
    • Jain L, Vargo CA, Danesi R, Sissung TM, Price DK, Venzon D, Venitz J, Figg WD. The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors. Mol Cancer Ther 2009, 8:2496-2508. 10.1158/1535-7163.MCT-09-0302, 2751847, 19755511.
    • (2009) Mol Cancer Ther , vol.8 , pp. 2496-2508
    • Jain, L.1    Vargo, C.A.2    Danesi, R.3    Sissung, T.M.4    Price, D.K.5    Venzon, D.6    Venitz, J.7    Figg, W.D.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.